
Prospects for robotic technology in endovascular treatment
How is it used and what is the potential?
A big advancement in modern medicine is the growth of minimally invasive procedures. These procedures have lowered the risk associated with complex surgeries as well as the recovery time needed by the patient.
How is robotic technology used in endovascular treatment?
What potential impact can remote technology have on the future of robotic-assisted endovascular procedures?
The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.
CorPath GRX Robotic system for neurovascular applications is available in select markets; it is not for sale in the USA, its future availability cannot be guaranteed.
Remote telerobotic applications are currently under development; they are not for sale. Their future availability cannot be guaranteed.